Articles

‘Attracting success’

Evotec, Sanofi launch multifaceted strategic alliance with outsourcing, library sharing
Written byKelsey Kaustinen
| 3 min read

HAMBURG, Germany—Negotiations that began last December have culminated in a major multicomponent strategic alliance for Evotec AG and Sanofi that will extend over the next five years. The companies have signed a definitive agreement for a discovery service collaboration that will include initiatives with both of Evotec’s business segments, EVT Execute and EVT Innovate. Under the agreement, Sanofi will pay Evotec a minimum guaranteed commitment of €250 million (about $278 million), including an upfront cash payment of more than €40 million.

“Sanofi is pleased to welcome Evotec as a new strategic partner in France. We highly value this collaboration, which will reinforce Toulouse Biopark as a major biomedical research platform in Europe and create a field of opportunities for our employees, while contributing to the vitality of the local ecosystem,” Dr. Elias Zerhouni, president of Global R&D for Sanofi, noted in a press release.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A scientist in protective laboratory attire examines a sample under a microscope, surrounded by digital overlays of DNA strands, molecular structures, scientific symbols, and data graphics.
From automated experiments to AI-powered analysis, connected data, and smarter resource use, digital technologies are reshaping how scientists work — and what the laboratory itself can do.
A scientist in protective laboratory attire examines a sample under a microscope, surrounded by digital overlays of DNA strands, molecular structures, scientific symbols, and data graphics.
From automated experiments to AI-powered analysis, connected data, and smarter resource use, digital technologies are reshaping how scientists work — and what the laboratory itself can do.
Blue microscopic illustration of spherical cells with textured surfaces against a dark background.
Explore how longitudinal single-cell profiling of whole blood can reveal immune signatures associated with CAR T cell therapy-related neurotoxicity.